Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)

Daniel J. Sheward, Changil Kim, Roy A. Ehling, Alec Pankow, View ORCID ProfileXaquin Castro Dopico, Darren Martin, Sai Reddy, Joakim Dillner, Gunilla B. Karlsson Hedestam, Jan Albert, Ben Murrell
doi: https://doi.org/10.1101/2021.12.19.473354
Daniel J. Sheward
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
2Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changil Kim
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy A. Ehling
3Department of Biosystems Science and Engineering, ETH Zürich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alec Pankow
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xaquin Castro Dopico
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xaquin Castro Dopico
Darren Martin
2Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sai Reddy
3Department of Biosystems Science and Engineering, ETH Zürich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joakim Dillner
4Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunilla B. Karlsson Hedestam
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Albert
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
5Dept of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Murrell
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: benjamin.murrell@ki.se
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article usage

Article usage: December 2021 to March 2023

AbstractFullPdf
Dec 20211960116665
Jan 202260689241
Feb 20221472945
Mar 20221171128
Apr 202262629
May 202275722
Jun 202251811
Jul 202282410
Aug 2022581915
Sep 202236517
Oct 202254715
Nov 202252410
Dec 202236315
Jan 202331614
Feb 202326514
Mar 20233703
Back to top
PreviousNext
Posted December 20, 2021.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
Daniel J. Sheward, Changil Kim, Roy A. Ehling, Alec Pankow, Xaquin Castro Dopico, Darren Martin, Sai Reddy, Joakim Dillner, Gunilla B. Karlsson Hedestam, Jan Albert, Ben Murrell
bioRxiv 2021.12.19.473354; doi: https://doi.org/10.1101/2021.12.19.473354
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
Daniel J. Sheward, Changil Kim, Roy A. Ehling, Alec Pankow, Xaquin Castro Dopico, Darren Martin, Sai Reddy, Joakim Dillner, Gunilla B. Karlsson Hedestam, Jan Albert, Ben Murrell
bioRxiv 2021.12.19.473354; doi: https://doi.org/10.1101/2021.12.19.473354

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4233)
  • Biochemistry (9128)
  • Bioengineering (6774)
  • Bioinformatics (23989)
  • Biophysics (12117)
  • Cancer Biology (9523)
  • Cell Biology (13773)
  • Clinical Trials (138)
  • Developmental Biology (7627)
  • Ecology (11686)
  • Epidemiology (2066)
  • Evolutionary Biology (15506)
  • Genetics (10638)
  • Genomics (14322)
  • Immunology (9479)
  • Microbiology (22832)
  • Molecular Biology (9089)
  • Neuroscience (48981)
  • Paleontology (355)
  • Pathology (1480)
  • Pharmacology and Toxicology (2568)
  • Physiology (3844)
  • Plant Biology (8327)
  • Scientific Communication and Education (1471)
  • Synthetic Biology (2296)
  • Systems Biology (6187)
  • Zoology (1300)